{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:34:01Z","timestamp":1792370041891,"version":"4.4.0"},"reference-count":53,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej20-0178","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T22:06:34Z","timestamp":1597701994000},"page":"893-902","source":"Crossref","is-referenced-by-count":30,"title":["The applications of androgen in the treatment of dry eye disease: a systematic review of clinical studies"],"prefix":"10.1507","volume":"67","author":[{"given":"Lixiang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Pflugfelder SC (2008) Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care 14: S102\u2013S106."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N (2018) Prevalence and risk factors of dry eye disease in North India: ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol 66: 207\u2013211.","DOI":"10.4103\/ijo.IJO_698_17"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Song P, Xia W, Wang M, Chang X, Wang J, et al. (2018) Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis. J Glob Health 8: 020503.","DOI":"10.7189\/jogh.08.020503"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Alshamrani AA, Almousa AS, Almulhim AA, Alafaleq AA, Alosaimi MB, et al. (2017) Prevalence and risk factors of dry eye symptoms in a Saudi Arabian population. Middle East Afr J Ophthalmol 24: 67\u201373.","DOI":"10.4103\/meajo.MEAJO_281_16"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Farrand KF, Fridman M, Stillman IO, Schaumberg DA (2017) Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol 182: 90\u201398.","DOI":"10.1016\/j.ajo.2017.06.033"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Yen JC, Hsu CA, Li YC, Hsu MH (2015) The prevalence of dry eye syndrome\u2019s and the likelihood to develop Sj\u00f6gren\u2019s syndrome in Taiwan: a population-based study. Int J Environ Res Public Health 12: 7647\u20137655.","DOI":"10.3390\/ijerph120707647"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Schaumberg DA, Dana R, Buring JE, Sullivan DA (2009) Prevalence of dry eye disease among US men: estimates from the physicians\u2019 health studies. Arch Ophthalmol 127: 763\u2013768.","DOI":"10.1001\/archophthalmol.2009.103"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, et al. (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15: 438\u2013510.","DOI":"10.1016\/j.jtos.2017.05.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Jonas JB, Wei WB, Xu L, Rietschel M, Streit F, et al. (2018) Self-rated depression and eye diseases: the beijing eye study. PLoS One 13: e0202132.","DOI":"10.1371\/journal.pone.0202132"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Yu J, Asche CV, Fairchild CJ (2011) The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea 30: 379\u2013387.","DOI":"10.1097\/ICO.0b013e3181f7f363"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Song X, Zhao P, Wang G, Zhao X (2014) The effects of estrogen and androgen on tear secretion and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats. Invest Ophthalmol Vis Sci 55: 745\u2013751.","DOI":"10.1167\/iovs.12-10457"},{"key":"12","unstructured":"12 Luo F, Zhang H, Sun X (2001) The change of tear secretion and tear film stability in castrated male rabbits. Zhonghua Yan Ke Za Zhi 37: 458\u2013461 (In Chinese)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls DB, et al. (2000) Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 85: 4874\u20134882.","DOI":"10.1210\/jc.85.12.4874"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Gao J, Lambert RW, Wickham LA, Banting G, Sullivan DA (1995) Androgen control of secretory component mRNA levels in the rat lacrimal gland. J Steroid Biochem Mol Biol 52: 239\u2013249.","DOI":"10.1016\/0960-0760(94)00172-I"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Sullivan DA, Kelleher RS, Vaerman JP, Hann LE (1990) Androgen regulation of secretory component synthesis by lacrimal gland acinar cells <i>in vitro<\/i>. J Immunol 145: 4238\u20134244.","DOI":"10.4049\/jimmunol.145.12.4238"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, et al. (2000) Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 84: 76\u201384.","DOI":"10.1136\/bjo.84.1.76"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Driver PJ, Lemp MA (1996) Meibomian gland dysfunction. Surv Ophthalmol 40: 343\u2013367.","DOI":"10.1016\/S0039-6257(96)80064-6"},{"key":"18","unstructured":"18 Sullivan DA, Jensen RV, Suzuki T, Richards SM (2009) Do sex steroids exert sex-specific and\/or opposite effects on gene expression in lacrimal and meibomian glands? Mol Vis 15: 1553\u20131572."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yamagami H, et al. (2002) Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 966: 211\u2013222.","DOI":"10.1111\/j.1749-6632.2002.tb04217.x"},{"key":"20","unstructured":"20 Sullivan DA (2004) Androgen deficiency &amp; dry eye syndromes. Arch Soc Esp Oftalmol 79: 49\u201350."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Sullivan DA, Yamagami H, Liu M, Steagall RJ, Schirra F, et al. (2002) Sex steroids, the meibomian gland and evaporative dry eye. Adv Exp Med Biol 506: 389\u2013399.","DOI":"10.1007\/978-1-4615-0717-8_56"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Cermak JM, Krenzer KL, Sullivan RM, Dana MR, Sullivan DA (2003) Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea 22: 516\u2013521.","DOI":"10.1097\/00003226-200308000-00006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Sullivan BD, Evans JE, Cermak JM, Krenzer KL, Dana MR, et al. (2002) Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol 120: 1689\u20131699.","DOI":"10.1001\/archopht.120.12.1689"},{"key":"24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/GME.0000000000000530","volume":"23","author":"I Sriprasert","year":"2016","unstructured":"24 Sriprasert I, Warren DW, Mircheff AK, Stanczyk FZ (2016) Dry eye in postmenopausal women: a hormonal disorder. Menopause 23: 343\u2013351.","journal-title":"Menopause","ISSN":"https:\/\/id.crossref.org\/issn\/1072-3714","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Yasui T, Matsui S, Tani A, Kunimi K, Yamamoto S, et al. (2012) Androgen in postmenopausal women. J Med Invest 59: 12\u201327.","DOI":"10.2152\/jmi.59.12"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Grossmann M, Wu FC (2014) Male androgen deficiency: a multisystem syndrome. Asian J Androl 16: 159\u2013160.","DOI":"10.4103\/1008-682X.122587"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Azcarate PM, Venincasa VD, Feuer W, Stanczyk F, Schally AV, et al. (2014) Androgen deficiency and dry eye syndrome in the aging male. Invest Ophthalmol Vis Sci 55: 5046\u20135053.","DOI":"10.1167\/iovs.14-14689"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Truong S, Cole N, Stapleton F, Golebiowski B (2014) Sex hormones and the dry eye. Clin Exp Optom 97: 324\u2013336.","DOI":"10.1111\/cxo.12147"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, et al. (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4: 1.","DOI":"10.1186\/2046-4053-4-1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, et al. (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343: d5928.","DOI":"10.1136\/bmj.d5928"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Dent O (2003) Methodological index for non-randomized studies. ANZ J Surg 73: 675\u2013676.","DOI":"10.1046\/j.1445-2197.2003.02762.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Supalaset S, Tananuvat N, Pongsatha S, Chaidaroon W, Ausayakhun S (2019) A randomized controlled double-masked study of transdermal androgen in dry eye patients associated with androgen deficiency. Am J Ophthalmol 197: 136\u2013144.","DOI":"10.1016\/j.ajo.2018.09.021"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Golebiowski B, Badarudin N, Eden J, Gerrand L, Robinson J, et al. (2017) The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study. Br J Ophthalmol 101: 926\u2013932.","DOI":"10.1136\/bjophthalmol-2016-309498"},{"key":"34","unstructured":"34 Connor CG (2003) Treatment of dry eye with a transdermal 3% testosterone cream. IOVS 44: 2450."},{"key":"35","unstructured":"35 Connor CG (2008) Evaporative dry eye treated with transdermal testosterone. IOVS 49: 120."},{"key":"36","unstructured":"36 Connor CG (2009) Androgenic cream treatment most efficacious for women 40 to 60 with dry eye. IOVS 50: 4656."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Connor C, Karkkainen T (2001) The efficacy of androgenic artificial tears in the treatment of dry eye. Scientific Program of 78th Annual Meetings of American Academy of Optometry, R114-3: 40 pm (Abstract).","DOI":"10.1097\/00006324-200112001-00185"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, et al. (2004) Pilot clinical trial of dehydroepiandrosterone (DHEA) <i>versus<\/i> placebo for Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 51: 601\u2013604.","DOI":"10.1002\/art.20540"},{"key":"39","unstructured":"39 Valtysd\u00f3ttir ST, Wide L, H\u00e4llgren R (2001) Low serum dehydroepiandrosterone sulfate in women with primary Sj\u00f6gren\u2019s syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 28: 1259\u20131265."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Valtysdottir ST, Wide L, Hallgren R (2003) Mental wellbeing and quality of sexual life in women with primary Sj\u00f6gren\u2019s syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Rheum Dis 62: 875\u2013879.","DOI":"10.1136\/ard.62.9.875"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Supalaset S, Tananuvat N, Pongsatha S, Chaidaroon W, Ausayakhun S (2018) A randomized controlled double-masked study of transdermal androgen in dry eye patients associated with androgen deficiency. Am J Ophthalmol 197: 136\u2013144.","DOI":"10.1016\/j.ajo.2018.09.021"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Laurent MR, Helsen C, Antonio L, Schollaert D, Joniau S, et al. (2016) Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity <i>in vitro<\/i>. Mol Cell Endocrinol 437: 280\u2013291.","DOI":"10.1016\/j.mce.2016.08.041"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Thorne I, Sutcliffe N (2017) Sj\u00f6gren\u2019s syndrome. Br J Hosp Med (Lond) 78: 438\u2013442.","DOI":"10.12968\/hmed.2017.78.8.438"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, et al. (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15: 539\u2013574.","DOI":"10.1016\/j.jtos.2017.05.001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Tong L, Teng LS (2018) Review of literature on measurements of non-invasive break up times, lipid morphology and tear meniscal height using commercially available hand-held instruments. Curr Eye Res 43: 567\u2013575.","DOI":"10.1080\/02713683.2018.1437454"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Sook Chun Y, Park IK (2014) Reliability of 4 clinical grading systems for corneal staining. Am J Ophthalmol 157: 1097\u20131102.","DOI":"10.1016\/j.ajo.2014.02.012"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Trost LW, Mulhall JP (2016) Challenges in testosterone measurement, data interpretation, and methodological appraisal of interventional trials. J Sex Med 13: 1029\u20131046.","DOI":"10.1016\/j.jsxm.2016.04.068"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD (2003) Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 58: 710\u2013717.","DOI":"10.1046\/j.1365-2265.2003.01772.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Bhasin S, Pencina M, Jasuja GK, Travison TG, Coviello A, et al. (2011) Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab 96: 2430\u20132439.","DOI":"10.1210\/jc.2010-3012"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Dhiman P, Bhansali A, Prasad R, Dutta P, Walia R, et al. (2011) Predictors of pilosebaceous unit responsiveness to testosterone therapy in patients with hypogonadotrophic hypogonadism. Andrologia 43: 422\u2013427.","DOI":"10.1111\/j.1439-0272.2010.01093.x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Pardridge WM (1986) Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 15: 259\u2013278.","DOI":"10.1016\/S0300-595X(86)80024-X"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M, et al. (2011) Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 165: 675\u2013685.","DOI":"10.1530\/EJE-11-0221"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Shoskes JJ, Wilson MK, Spinner ML (2016) Pharmacology of testosterone replacement therapy preparations. Transl Androl Urol 5: 834\u2013843.","DOI":"10.21037\/tau.2016.07.10"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/9\/67_EJ20-0178\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T22:10:59Z","timestamp":1696543859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/9\/67_EJ20-0178\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0178","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}